alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest studies

Every summary in our library, newest first, as a dated timeline.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 18,076–18,100 of 27,380 studies, newest first · page 724 of 1096.

February 2014 9

  1. 2014-02-01

    Cross-boundary Cancer Studies at the University of Tokyo: Food and Cancer

    ✓ Peer-reviewed Risk factors Japanese Journal of Clinical Oncology

    Key finding: He has been actively delivering lectures on the prevention of diseases associated with adult lifestyle habits and the preservation of the global environment via ‘shokuiku,’ or food education. +2 more findings

    Full summary, score breakdown and related studies → Original source

  2. 2014-02-01

    Development and validation of a brief dementia screening indicator for primary care

    ✓ Peer-reviewed Long-term cohort studies Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: The final Dementia Screening Indicator included age (1 point/year; ages, 65-79 years), less than 12 years of education (9 points), stroke (6 points), diabetes mellitus (3 points), body mass index less than 18.5 kg/m(2) (8 points), requiring assistance with money or medications (10 points), and depressive symptoms (6 points). +3 more findings

    Full summary, score breakdown and related studies → Original source

  3. 2014-02-01

    Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations

    ✓ Peer-reviewed Lewy body dementia Neuron

    Key finding: TDP-43 is a major component of the cytoplasmic inclusions characteristic of amyotrophic lateral sclerosis and some types of frontotemporal lobar degeneration. +4 more findings

    Full summary, score breakdown and related studies → Original source

  4. 2014-02-01

    The glutamatergic hypothesis for Down syndrome: the potential use of N-methyl-D-aspartate receptor antagonists to enhance cognition and decelerate neurodegeneration

    ✓ Peer-reviewed Down syndrome and Alzheimer's CNS & neurological disorders drug targets

    Key finding: Recent preclinical and clinical work on the N-methyl-D-aspartate (NMDA) receptor antagonist memantine give us some reason for optimism, at least in relation to the potential for a partial pharmacological improvement of hippocampus dependent memory deficits associated with DS. +1 more finding

    Full summary, score breakdown and related studies → Original source

  5. 2014-02-01

    Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer's disease and Down syndrome

    ✓ Peer-reviewed Down syndrome and Alzheimer's Neuropathology and applied neurobiology

    Key finding: Phosphorylation of tau protein at the carboxyl terminus may be among the earliest tau events, and it occurs prior to the apparition of the classical fibrillar structure. +1 more finding

    Full summary, score breakdown and related studies → Original source

  6. 2014-02-01

    Postoperative cognitive dysfunction

    ✓ Peer-reviewed Getting a diagnosis Deutsches Arzteblatt international

    Key finding: POCD can markedly impair postoperative recovery. +2 more findings

    Full summary, score breakdown and related studies → Original source

  7. 2014-02-01

    Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease

    ✓ Peer-reviewed Prevention and risk Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: A link between Alzheimer's disease (AD) and metabolic disorders has been established, with patients with type 2 diabetes at increased risk of developing AD and vice versa. +1 more finding

    Full summary, score breakdown and related studies → Original source

  8. 2014-02-01

    Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial

    ✓ Peer-reviewed Treatments JAMA

    Key finding: Among patients with probable Alzheimer disease and agitation who were receiving psychosocial intervention, the addition of citalopram compared with placebo significantly reduced agitation and caregiver distress; however, cognitive and cardiac adverse effects of citalopram may limit its practical application at the dosage of 30 mg per day. +4 more findings

    Full summary, score breakdown and related studies → Original source

  9. 2014-02 month only

    The Costs of Dementia From the Societal Perspective: Is Care Provided in the Community Really Cheaper Than Nursing Home Care?

    ✓ Peer-reviewed Costs and economics Journal of the American Medical Directors Association

    Key finding: Unadjusted annual societal costs were €29,930 (community) vs €33,482 (nursing home) per patient +3 more findings

    Full summary, score breakdown and related studies → Original source

January 2014 16

  1. 2014-01-30

    Active immunotherapy options for Alzheimer's disease

    ✓ Peer-reviewed Drug development Alzheimer's research & therapy

    Key finding: AD pathogenesis is associated with the accumulation of amyloid-beta protein (Aβ) and/or hyperphosphorylated tau protein in the brain. +3 more findings

    Full summary, score breakdown and related studies → Original source

  2. 2014-01-30

    Speech in Alzheimer's disease: can temporal and acoustic parameters discriminate dementia?

    ✓ Peer-reviewed Digital health tools Dementia and geriatric cognitive disorders

    Key finding: These measures offer a sensitive method of assessing spontaneous speech output in AD, and they discriminate well between people with AD and healthy older adults. +1 more finding

    Full summary, score breakdown and related studies → Original source

  3. 2014-01-29

    Diabetes mellitus and the risk of Alzheimer's disease: a nationwide population-based study

    ✓ Peer-reviewed Costs and economics PloS one

    Key finding: Newly diagnosed DM was associated with increased risk of AD. +4 more findings

    Full summary, score breakdown and related studies → Original source

  4. 2014-01-29

    Prevalence of cortical superficial siderosis in a memory clinic population

    ✓ Peer-reviewed Brain scans and imaging Neurology

    Key finding: Agreement for detection of SS was excellent (unweighted κ of 0.81). +1 more finding

    Full summary, score breakdown and related studies → Original source

  5. 2014-01-29

    Confidentiality in preclinical Alzheimer disease studies: when research and medical records meet

    ✓ Peer-reviewed Biomarkers Neurology

    Key finding: An individual enrolled in a research study that uses positive test results from amyloid PET imaging or CSF measures of β-amyloid 42 as inclusion criteria has biomarkers indicative of AD pathology. +2 more findings

    Full summary, score breakdown and related studies → Original source

  6. 2014-01-28

    A claims data-based comparison of comorbidity in individuals with and without dementia

    ✓ Peer-reviewed Prevention and risk BMC geriatrics

    Key finding: Individuals with dementia were more likely to be diagnosed with 15 comorbidity complexes, including Parkinson's, stroke, diabetes, atherosclerosis (supposed dementia risk factors) or fluids and electrolyte disorders, insomnia, incontinence, pneumonia, fractures and injuries (supposed sequelae). +2 more findings

    Full summary, score breakdown and related studies → Original source

  7. 2014-01-27

    Glucagon-like peptide-1 protects synaptic and learning functions from neuroinflammation in rodents

    ✓ Peer-reviewed Drug development Journal of neuroscience research

    Key finding: In the Y-maze test, LPS (10 μg/mouse, i.c.v) significantly decreased the percentage alternation. +1 more finding

    Full summary, score breakdown and related studies → Original source

  8. 2014-01-23

    Family caregiver challenges in dementia care in Australia and China: a critical perspective

    ✓ Peer-reviewed Caregiving BMC geriatrics

    Key finding: In total 148 caregivers participated in the project with 57 of them from Australia (26 and 31 in the qualitative and quantitative strands respectively) and 91 of them from China (23 and 68 in the qualitative and quantitative strands respectively). +4 more findings

    Full summary, score breakdown and related studies → Original source

  9. 2014-01-23

    What is the current state of care for older people with dementia in general hospitals? A literature review

    ✓ Peer-reviewed Costs and economics Dementia (London, England)

    Key finding: Significantly, this review highlights that overall there remains mostly negative consequences and outcomes for people with dementia when they go into general hospitals. +1 more finding

    Full summary, score breakdown and related studies → Original source

  10. 2014-01-23

    c-Jun N-terminal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo

    ✓ Peer-reviewed Disease mechanisms Cell death & disease

    Key finding: We here characterized the pathways leading to synaptopathy in TgCRND8 mice and showed that c-Jun N-terminal kinase (JNK) is activated at the spine prior to the onset of cognitive impairment.

    Full summary, score breakdown and related studies → Original source

  11. 2014-01-22

    Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI study

    ✓ Peer-reviewed Hippocampus size on brain scans Neurology

    Key finding: A higher omega-3 index was correlated with larger total normal brain volume and hippocampal volume in postmenopausal women measured 8 years later. +2 more findings

    Full summary, score breakdown and related studies → Original source

  12. 2014-01-22

    Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

    ✓ Peer-reviewed Treatments New England Journal of Medicine

    Solanezumab, a humanized monoclonal antibody that binds amyloid, failed to improve cognition or functional ability.

    Full summary, score breakdown and related studies → Original source

  13. 2014-01-22

    APOE ε4 worsens hippocampal CA1 apical neuropil atrophy and episodic memory

    ✓ Peer-reviewed Genetics Neurology

    Key finding: The APOE ε4 allele segregated dose-dependently and selectively with CA1-SRLM thinning and worse episodic memory performance in a pool of older subjects across a cognitive spectrum. +3 more findings

    Full summary, score breakdown and related studies → Original source

  14. 2014-01-21

    Barriers to advance care planning in cancer, heart failure and dementia patients: a focus group study on general practitioners' views and experiences

    ✓ Peer-reviewed End-of-life care PloS one

    Key finding: The results of our study contribute to a better understanding of the factors hindering GPs in initiating ACP. +1 more finding

    Full summary, score breakdown and related studies → Original source

  15. 2014-01-21

    Grey matter changes in cognitively impaired Parkinson's disease patients

    ✓ Peer-reviewed Brain scans and imaging PloS one

    Key finding: Grey matter changes in PDD involve areas associated with Alzheimer-like pathology while fronto-parietal abnormalities are possibly an early marker of PD cognitive decline. +3 more findings

    Full summary, score breakdown and related studies → Original source

  16. 2014-01-20

    Age-dependent postoperative cognitive impairment and Alzheimer-related neuropathology in mice

    ✓ Peer-reviewed Risk genes beyond APOE Scientific reports

    Key finding: However, its pathogenesis remains largely to be determined. +3 more findings

    Full summary, score breakdown and related studies → Original source

Browse the library by subject, with the full score breakdown →